International Journal of Current Research and Review
ISSN: 2231-2196 (Print)ISSN: 0975-5241 (Online)
Bootstrap Slider

Indexed and Abstracted in: SCOPUS, Crossref, CAS Abstracts, Publons, CiteFactor, Open J-Gate, ROAD, Indian Citation Index (ICI), Indian Journals Index (IJINDEX), Internet Archive, IP Indexing, Google Scholar, Scientific Indexing Services, Index Copernicus, Science Central, Revistas Medicas Portuguesas, EBSCO, BOAI, SOROS, NEWJOUR, ResearchGATE, Ulrich's Periodicals Directory, DocStoc, PdfCast, getCITED, SkyDrive, Citebase, e-Print, WorldCat (World's largest network of library content and services), Electronic Journals Library by University Library of Regensburg, SciPeople.

Search Articles

Track manuscript

Readers around the world

Full Html

IJCRR - vol 05 issue 19, October, 2013

Pages: 81-87

Date of Publication: 19-Oct-2013


Print Article   Download XML  Download PDF

PREVALENCE AND ANTIMICROBIAL SUSCEPTIBILITY PATTERN OF EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE ISOLATED FROM RESPIRATORY SAMPLES IN A SOUTH INDIAN TERTIARY CARE HOSPITAL

Author: Ranjan Basu , Raghav Rao, Arijit Sarkar, Bidyarani Kongbrailatpam

Category: Healthcare

Abstract:Objective: Klebsiella pneumoniae is important in causing a classic form of primary pneumonia and the leading causes of nosocomial infection, being hard to eradicate due to development of multidrug-resistant strains that produce extended\?spectrum beta-lactamase (ESBL) enzyme. The present study was conducted to find out the prevalence and antimicrobial susceptibility pattern of respiratory isolates of ESBL producing Klebsiella pneumoniae at our hospital . Methods: Respiratory samples of RTI patients from different IPDs and OPDs sent for culture and sensitivity prior to starting of any antibiotics, during January 2012 to June 2013 were included in the study. Klebsiella pneumoniae was identified by standard laboratory procedure as per CLSI guideline. Antimicrobial susceptibility testing was done by Kirby-Bauer's disk diffusion method in Mueller Hinton Agar media. ESBL producing strains were confirmed by Double Disk Synergy test after initial screening with 3rd generation cephalosporins. Results: Out of 400 respiratory samples ,140 Klebsiella pneumoniae were isolated among which 38 ( 27.14 % ) were ESBL producers and 102 ( 72.86 % ) were non ESBL strains . A 131 ( 93.57% ) isolates were obtained from IPDs. and 9 ( 6.43 %) were from OPDs .Male to female ratio for ESBL producing K. pneumonia was 1.7 : 1. TBCD dept. and ICCU were the major contributors of those positive isolates. A 64% multi drug resistance were observed among ESBL isolates. Apart from 3rd generation cephalosporins, they were also highly resistant to common antibiotics like Ampicillin, Aztreonam, Gentamycin, Erythromycin and Co-trimoxazole. Imipenem was the most active antibiotics with 96.37% susceptibility rates. Conclusions: Regular monitoring on the judicious use of antibiotics helps in preserving the effectiveness and emergence of further resistance of the sensitive antibiotics among the ESBL producing K. pneumonia.

Keywords: Klebsiella pneumoniae, susceptibility, ESBL producers , antimicrobial resistance

Full Text:

INTRODUCTION

 Klebsiella pneumoniae is a Gram-negative, non-motile, encapsulated, lactose fermenting, facultative anaerobic, rod shaped bacterium found in the normal flora of the mouth, skin and intestines. In the recent years, klebsiella pneumoniae has become important pathogen in nosocomial infections. Klebsiella pneumoniae being the primary cause of respiratory tract infections, is most frequently recovered from clinical specimens and can cause a classic form of primary pneumonia. Klebsiella pneumoniae can also cause a variety of extrapulmonary infections, including enteritis and meningitis in infants, urinary tract infections in children and adults and septicaemia1. They are ubiquitously present and 

reported worldwide. These bacteria have become important pathogens in nosocomial infections 2 which have been well documented in United States and India3. Epidemic and endemic nosocomial infections caused by Klebsiella species are leading causes of morbidity and mortality4. In the United States, Klebsiella accounts for 3-7% of all nosocomial bacterial infections, placing them among the eight most important infectious pathogens in hospitals. Klebsiellae have a tendency to harbour antibiotic resistant plasmids; thus, infections with multiple antibiotic-resistant strains can be anticipated.1

Multidrug resistant bacteria cause serious nosocomial and community acquired infections that are hard to eradicate by using available antibiotics. Moreover, extensive use of broad-spectrum antibiotics in hospitalized patients has led to both increased carriage of Klebsiella pneumoniae and the development of multidrug-resistant strains that produce extended–spectrum beta-lactamase (ESBL). The first ESBL producing strain discovered in Germany was Klebsiella pneumoniae in 1980s. Outbreaks of ESBL-producing Klebsiella pneumoniae infections have increased worldwide 5. Recently, World Health Organization also warned the community that multidrug resistant bacteria are emerging worldwide which is a big challenge to healthcare. If we don’t take immediate action then antibiotics may lose their power to cure diseases caused by this bacteria6.

Area-wise studies on antimicrobial susceptibility profiles are essential to guide policy on the appropriate use of antibiotics. The present study was conducted to find out the prevalence of ESBL producing Klebsiella pneumoniae in respiratory samples of patients with respiratory tract infections along with their antimicrobial susceptibility pattern at our hospital. The information would be useful in establishing empiric therapy guidelines to prevent the emergence of further resistance and to contribute data to larger more extensive surveillance programs.

MATERIALS AND METHODS

The present study was conducted in the department of Microbiology, GSL Medical College and General Hospital, Rajahmundry, Andhra Pradesh, India. Patients having symptoms of respiratory tract infections diagnosed provisionally in different IPDs and OPDs whose respiratory samples (sputum / throat swab / bronchial washings) were sent for culture and sensitivity prior to starting of any antibiotics, during the period from January 2012 to June 2013 were included in the study . Informed consent was taken from the patient and ethical clearance was obtained from the institute.

400 respiratory samples received during that period were inoculated in MacConkey’s agar, Blood agar and Nutrient agar media and routine standard operative procedures are followed in the laboratory in isolating and identifying the organisms from the sputum samples. Klebsiella pneumoniae was identified by typical mucoid, lactose fermenting colony, Gram stain morphology, motility test, oxidase test, urease production test, IMViC reaction, fermentation of sugars like glucose, lactose, sucrose, mannitol with production of acid and gas.

Antimicrobial susceptibility testing was done by Kirby-Bauer disk diffusion method in Mueller Hinton agar media and results are interpreted according to the Clinical and Laboratory Standards Institute (CLSI) guidelines 7. Standard antibiotics like ampicillin (10 mcg), amoxyclav          (20/10 mcg), piperacillin/tazobactum (100 /10 mcg), ceftriaxone (30 mcg), cefotaxime (30 mcg), ceftazidime (30 mcg), cefepime (30 mcg), imipenem (10 mcg), aztreonam (30 mcg), ciprofloxacin  (5 mcg) ,  levofloxacin (5 mcg) , co-trimoxazole (1.25/23.75 mcg) gentamycin (10 mcg), amikacin (30 mcg) and erythromycin (15 mcg)8 were tested (HIMEDIA, MUMBAI, INDIA) 

Detection of ESBL

All Klebsiella pneumoniae isolates showing resistance to 3rd generation cephalosporins like cefotaxime, ceftazidime and ceftriaxone were screened initially for probable ESBL producing strains which were followed by the phenotypic confirmatory test for confirmation of  ESBL producing isolates.  The double-disk synergy test was used to confirm ESBL strains. In brief, ceftazidime (30 mcg), cefotaxime (30 μg) and ceftriaxone (30 μg)  were placed at a distances of 30 mm from center to center and around a disk containing amoxicillin (20 μg) plus clavulanic acid (10 μg). The results were interpreted as positive when the difference in zones of inhibition of isolates was > 5 mm in combination with clavulanic acid than to ceftazidime, cefotaxime or ceftriaxone alone. Enhancement of the inhibition zone toward the amoxicillin-plus-clavulanic acid disk is suggestive of ESBL production. 9,10,7

The data obtained in this study was summarized by counts and percentages. Antibiotic Susceptibility rates were presented with the respective 95% confidence interval values.

RESULTS

Out of a total 400 respiratory samples (sputum and broncho-alveolar lavage) received in our central laboratory during the period from January 2012 – June 2013, 140 (35%) Klebsiella pneumoniae were isolated. Among the 140 K. Pneumoniae isolates, 38 ( 27.14 %  ) were ESBL producing strains as confirmed by double disk synergy test and 102 ( 72.86 % ) were non ESBL strains; among them  107 (76.43%) were from male patient and 33 (23.57 %) were from females whereas 131 ( 93.57 % ) isolates were obtained from In Patient Dept. and 9 ( 6.43 %)  were from OPDs; The distribution of ESBL and Non ESBL strains , sex wise and IPD / OPD wise  are shown in  Table – 1 . There was no significant age specificity  noted in our study . Over all male to female ratio was  3.25 : 1 whereas the male to female ratio of ESBL producing isolates was 1.7 : 1 .

Most of the Klebsiella pneumoniae  isolates from respiratory samples were received from the TBCD department ( 49 / 35.00 % ) followed by ICCU (36 / 25.71 % ) , General Medicine     (27 / 19.28 % ) , Surgery (19 / 13.57 % ) and lowest from CTVS department (  9 / 6.43  % )                (  Table – 2 ) .

The results of antimicrobial susceptibility of ESBL producing strains of  Klebsiella pneumoniae  to various antibiotics tested in this study are shown in Figure - 1  and Table – 3  . 95 % confidence interval data are also presented. Imipenem was the most active antibiotics with 96.37% susceptibility rates . The next best were Piperacillin plus Tazobactum Amoxyclav, Levofloxacin and Cefepime. Apart from the high resistance to all 3rd generation cephalosporins, they were also resistant to common  antibiotics like Ampicillin , Aztreonam , Gentamycin , Erythromycin and Co-trimoxazole .

DISCUSSION

The present study reveals that the ESBL producing strains of K. pneumoniae  is highly prevalent

(27.14 %)  in respiratory isolates from mostly hospitalized patients / IPDs which once again proves them to be an important cause of infection in hospitalized patients .   The admitted patients were the majority in contributing the ESBL producing K. pneumoniae as seen in 25.72 % IPD versus 1.42 % OPD patients among overall K. pneumoniae isolates from respiratory samples. The high rate of ESBLs among hospitalized patients is a global problem. It is generally thought that patients infected by an ESBL producing strains are at increased risk of treatment failure.

The prevalence of ESBL producers varies across continents and countries and also within hospitals11,12 . In India, the prevalence rate varies in different institutions from 28 to 84% 13. In our study the prevalence of ESBL producing K. pneumoniae in respiratory isolates was 27.14 %.  Subha et al. in the study of various clinical isolates in Chennai from South India, found ESBL 

production in 25.8 percent isolates 14. A study on ESBL producing K. pneumoniae in Kashmir by S. Ahmed et al showed a 16.7% prevalence of the same in samples from respiratory tract infection 15. Hadi Mehrgan et al showed that ESBL production was more often seen in K. pneumoniae isolated from respiratory specimens 16 .

The male to female ratio of ESBL producing isolates was 1.7 : 1 which was supported by a study at Gulbarga by Renuka R. et al revealing slightly higher prevalence in males  than among females 17.

Other than the 3rd generation cephalosporins, the ESBL producing strains of Klebsiella pneumonia showed higher resistance with commonly used  antibiotics like Gentamycin (60.53%), Co-trimoxazole (60.53%) , Aztreonam (57.89 %) , Ampicillin (57.89 %)  and Erythromycin (55.26 %) . They were highly sensitive to  Imipenem (97.36 %) followed by Piperacillin + Tazobactum       (76.32 %) , Amoxyclav (73.68 %) , Levofloxacin (73.68 %) and Cefepime           (65.78 %) . Among all ESBL producing  K. pneumoniae , 64 % was multidrug resistance showing resistance to more than four drugs . All these observation are in tandem with various study by R. Rampure et al 18 , M. M. Faizabadi et al 19 , S. Ahmed et al 15  and  A. Singh Sikarwar et al 20

The indiscriminate use of higher groups of antibiotics and plasmid mediated drug resistance are the probable contributors to the emergence of multi drug resistance strains of ESBL producing strains of Klebsiella pneumoniae. It has been discovered that the mutant gene for ESBL production also contributes for  resistance to other drugs.

CONCLUSIONS

Incidence of respiratory tract infection caused by Klebsiella pneumoniae is increasing worldwide and is a common cause of primary pneumonia affecting all age group which is further complicated by rapidly emerging strains of multi drug resistant ESBL producing Klebsiella pneumoniae. The inadvertent and indiscriminate use of 3rd generation cephalosporins and other antibiotics has lead to the emergence of multi drug resistant ESBL producing Klebsiella pneumoniae. Regular monitoring on the judicious use of antibiotics helps in preserving the effectiveness of the sensitive antibiotics. 

Our study aims to guide clinicians on starting empirical treatment and appropriate use of antibiotics  which not only reduces the morbidity and mortality in the patients infected with ESBL producing  Klebsiella pneumoniae  but also controls the emergence of further resistance to the still sensitive drugs .

References:

  1. R.Sarathbabu, T.V.Ramani, K.Bhaskara rao, Supriya Panda;  Antibiotic susceptibility pattern of Klebsiella pneumoniae isolated from sputum, urine and pus samples ; IOSR Journal of Pharmacy and Biological Sciences (IOSRJPBS) ISSN : 2278-3008 Volume 1, Issue 2 (May-June 2012), PP 04-09 
  2. P. Nordamann, G. Cuzon and T. Naas “ The real threat of Klebsiella  pneumonia   carbapenemase - producing bacteria” , Lancet Infec Dis.,2009,9 (4):228-236.
  3. Archana Singh Sikarwar and Harsh Vardhan Batra ; Prevalence of Antimicrobial Drug Resistance  of Klebsiellapneumoniae in India ; International Journal of Bioscience, Biochemistry and Bioinformatics, September 2011: Vol. 1, No. 3,
  4. S.J. Cryz, R. Furer and R. Germanier “Protection against fatal Klebsiella pneumonia burn wound sepsis by passive transfer of anticapsular polysaccharide”, Infect. Immun., 1985, 45: 139-142.
  5. Bradford PA.; Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat ;  Clin Microbiol Rev2001; 14 (4): 933- 51.
  6. S.Young Soo, WHO, Western Pacific region, press release , 7 April , 2011.
  7. Clinical and Laboratory Standard Institute; Performance standards for antimicrobial susceptibility testing; Clinical and Laboratory Standards Institute, Wayne; 2012; 22nd Informational Supplement : 32(3).
  8. Betty A. Forbes , Daniel F. Sahm , Alice S. Weissfeld ; Bailey and Scott’s Diagnostic Microbiology ; 12th edition ; 2007 : p- 210 .
  9. d'Azevedo PA, Gonçalves AL, Musskopf MI, Ramos CG, Dias CA. Laboratory tests in the detection of extended spectrum beta-lactamase production: National Committee for Clinical Laboratory Standards (NCCLS) screening test, the E-test, the double disk confirmatory test, and cefoxitin susceptibility testing. Braz J Infect Dis 2004; 8 (5): 372- 7.
  10. Collee JG, Fraser AG, Barry P Marmion, Simmons A.;Mackie and McCartney Practical Medical Microbiology ;14th Ed. Churchill Livingstone, London .1996 : 169
  11. 8. Babini GS, Livermore DM. Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997-1998. J Antimicrob Chemother. 2000;45:183–9. [PubMed: 10660500]
  12. Paterson DL, Bonomo RA. Extended-spectrum betalactamases: A clinical update. Clin Microbiol Rev. 2005;18:657–86.[PMCID: PMC1265908] [PubMed: 16223952].
  13. Das A, Ray P, Garg R, Kaur B. Proceedings of the Silver Jubilee Conference. New Delhi: All India Institute of Medical Sciences; 2001. Extended spectrum beta-lactamase production in Gram negative bacterial isolates from cases of septicemia.
  14. Shubha S, Ananthan S 2002. Extended spectrum betalactamase (ESBL) mediated resistance to third genretion cephalosporins among Klebsiella pneumoniae in Chennai. Indian J Med Microbiology, 20: 92-95.
  15. Ahmad S. Prevalence and Antimicrobial Susceptibility of Extended-spectrum β- Lactamase- producing klebsiella pneumoniae at a Microbiology Diagnostic Center in Kashmir. RMJ. 2009; 34(1): 68-71. 
  16. Hadi Mehrgan , Mohammad Rahbar , Zohreh Arab-Halvaii ;  High prevalence of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a tertiary care hospital in Tehran, Iran ;  J Infect Dev Ctries 2010; 4(3):132-138.
  17. Renuka Rampure, Ravindranath Gangane, Ajay Kumar Oli , Kelmani Chandrakanth. R; Prevalence of MDR-ESBL producing Klebsiella pneumoniae isolated from clinical Samples ; J. Microbiol. Biotech. Res., 2013, 3 (1):32-39.
  18. Reuka Rampure , Ravindranath Gangane, Ajay Kumar Oli , Kelmani Chandrakanth R.; Prevalence of  MDR – ESBL producing Klebsiella pneumoniae isolated from clinical samples ; J. Microbiolo. Biotech. Res.; 2013; 3 ( 1 ) : 32-39 .
  19. Mohammad Mehdi Feizabadi , Gelavizh Etemadi , Marveh Rehmati , Samira Mohammadi Yeganeh , Shiveh Shabanpur , Soroor Asadi ; Antibiotic resistance patterns and genetic analysis of Klebsiella pneumoniae isolates from the respiratory tract; Tanaflos; 2007 ; 6 ( 3 ) : 20-25 .
  20. Archana Singh Sikarwar, Harsh Vardhan Batra; Prevalence of antimicrobial drug resistance of Klebsiella pneumoniae in India; International Journal of Bioscience, Biochemistry  and Bioinformatics; Sept, 2011 : Vol. 1 , No. – 3.

Research Incentive Schemes

Awards, Research and Publication incentive Schemes by IJCRR

Best Article Award: 

One article from every issue is selected for the ‘Best Article Award’. Authors of selected ‘Best Article’ are rewarded with a certificate. IJCRR Editorial Board members select one ‘Best Article’ from the published issue based on originality, novelty, social usefulness of the work. The corresponding author of selected ‘Best Article Award’ is communicated and information of award is displayed on IJCRR’s website. Drop a mail to editor@ijcrr.com for more details.

Women Researcher Award:

This award is instituted to encourage women researchers to publish her work in IJCRR. Women researcher, who intends to publish her research work in IJCRR as the first author is eligible to apply for this award. Editorial Board members decide on the selection of women researchers based on the originality, novelty, and social contribution of the research work. The corresponding author of the selected manuscript is communicated and information is displayed on IJCRR’s website. Under this award selected women, the author is eligible for publication incentives. Drop a mail to editor@ijcrr.com for more details.

Emerging Researcher Award:

‘Emerging Researcher Award’ is instituted to encourage student researchers to publish their work in IJCRR. Student researchers, who intend to publish their research or review work in IJCRR as the first author are eligible to apply for this award. Editorial Board members decide on the selection of student researchers for the said award based on originality, novelty, and social applicability of the research work. Under this award selected student researcher is eligible for publication incentives. Drop a mail to editor@ijcrr.com for more details.


Best Article Award

A Study by Juna Byun et al. entitled "Study on Difference in Coronavirus-19 Related Anxiety between Face-to-face and Non-face-to-face Classes among University Students in South Korea" is awarded Best Article for Vol 12 issue 16
A Study by Sudha Ramachandra & Vinay Chavan entitled "Enhanced-Hybrid-Age Layered Population Structure (E-Hybrid-ALPS): A Genetic Algorithm with Adaptive Crossover for Molecular Docking Studies of Drug Discovery Process" is awarded Best article for Vol 12 issue 15
A Study by Varsha M. Shindhe et al. entitled "A Study on Effect of Smokeless Tobacco on Pulmonary Function Tests in Class IV Workers of USM-KLE (Universiti Sains Malaysia-Karnataka Lingayat Education Society) International Medical Programme, Belagavi" is awarded Best article of Vol 12 issue 14, July 2020
A study by Amruta Choudhary et al. entitled "Family Planning Knowledge, Attitude and Practice Among Women of Reproductive Age from Rural Area of Central India" is awarded Best Article for special issue "Modern Therapeutics Applications"
A study by Raunak Das entitled "Study of Cardiovascular Dysfunctions in Interstitial Lung Diseas epatients by Correlating the Levels of Serum NT PRO BNP and Microalbuminuria (Biomarkers of Cardiovascular Dysfunction) with Echocardiographic, Bronchoscopic and HighResolution Computed Tomography Findings of These ILD Patients" is awarded Best Article of Vol 12 issue 13 
A Study by Kannamani Ramasamy et al. entitled "COVID-19 Situation at Chennai City – Forecasting for the Better Pandemic Management" is awarded best article for  Vol 12 issue 12
A Study by Muhammet Lutfi SELCUK and Fatma COLAKOGLU entitled "Distinction of Gray and White Matter for Some Histological Staining Methods in New Zealand Rabbit's Brain" is awarded best article for  Vol 12 issue 11
A Study by Anamul Haq et al. entitled "Etiology of Abnormal Uterine Bleeding in Adolescents – Emphasis Upon Polycystic Ovarian Syndrome" is awarded best article for  Vol 12 issue 10
A Study by Arpita M. et al entitled "Estimation of Reference Interval of Serum Progesterone During Three Trimesters of Normal Pregnancy in a Tertiary Care Hospital of Kolkata" is awarded best article for  Vol 12 issue 09
A Study by Ilona Gracie De Souza & Pavan Kumar G. entitled "Effect of Releasing Myofascial Chain in Patients with Patellofemoral Pain Syndrome - A Randomized Clinical Trial" is awarded best article for  Vol 12 issue 08
A Study by Virendra Atam et. al. entitled "Clinical Profile and Short - Term Mortality Predictors in Acute Stroke with Emphasis on Stress Hyperglycemia and THRIVE Score : An Observational Study" is awarded best article for  Vol 12 issue 07
A Study by K. Krupashree et. al. entitled "Protective Effects of Picrorhizakurroa Against Fumonisin B1 Induced Hepatotoxicity in Mice" is awarded best article for issue Vol 10 issue 20
A study by Mithun K.P. et al "Larvicidal Activity of Crude Solanum Nigrum Leaf and Berries Extract Against Dengue Vector-Aedesaegypti" is awarded Best Article for Vol 10 issue 14 of IJCRR
A study by Asha Menon "Women in Child Care and Early Education: Truly Nontraditional Work" is awarded Best Article for Vol 10 issue 13
A study by Deep J. M. "Prevalence of Molar-Incisor Hypomineralization in 7-13 Years Old Children of Biratnagar, Nepal: A Cross Sectional Study" is awarded Best Article for Vol 10 issue 11 of IJCRR
A review by Chitra et al to analyse relation between Obesity and Type 2 diabetes is awarded 'Best Article' for Vol 10 issue 10 by IJCRR. 
A study by Karanpreet et al "Pregnancy Induced Hypertension: A Study on Its Multisystem Involvement" is given Best Paper Award for Vol 10 issue 09
Late to bed everyday? You may die early, get depression
Egg a day tied to lower risk of heart disease
88 Percent Of Delhi Population Has Vitamin D Deficiency: ASSOCHAM Report

List of Awardees

Awardees of COVID-19 Research

Woman Researcher Award

A Study by Neha Garg et al. entitled "Optimization of the Response to nCOVID-19 Pandemic in Pregnant Women – An Urgent Appeal in Indian Scenario" published in Vol 12 issue 09

A Study by Sana Parveen and Shraddha Jain entitled "Pathophysiologic Enigma of COVID-19 Pandemic with Clinical Correlates" published in Vol 12 issue 13

A Study by Rashmi Jain et al. entitled "Current Consensus Review Article on Drugs and Biologics against nCOVID-19 – A Systematic Review" published in Vol 12 issue 09

Emerging Researcher Award

A Study by Madhan Jeyaraman et al. entitled "Vitamin-D: An Immune Shield Against nCOVID-19" published in Vol 12 issue 09

Study by Dheeraj Kumar Chopra et al. entitled "Lipid-Based Solid Dispersions of Azilsartan Medoxomil with Improved Oral Bioavailability: In Vitro and In Vivo Evaluation" published in Vol 12 issue 19


RSS feed

Indexed and Abstracted in


Antiplagiarism Policy: IJCRR strongly condemn and discourage practice of plagiarism. All received manuscripts have to pass through "Plagiarism Detection Software" test before forwarding for peer review. We consider "Plagiarism is a crime"

IJCRR Code of Conduct: We at IJCRR voluntarily adopt policies on Code of Conduct, and Code of Ethics given by OASPA and COPE. To know about IJCRRs Code of Conduct, Code of Ethics, Artical Retraction policy, Digital Preservation Policy, and Journals Licence policy click here

Disclaimer: International Journal of Current Research and Review (JICRR) provides platform for researchers to publish and discuss their original research and review work. IJCRR can not be held responsible for views, opinions and written statements of researchers published in this journal.



Company name

International Journal of Current Research and Review (JICRR) provides platform for researchers to publish and discuss their original research and review work. IJCRR can not be held responsible for views, opinions and written statements of researchers published in this journal

Contact

148, IMSR Building, Ayurvedic Layout,
        Near NIT Complex, Sakkardara,
        Nagpur-24, Maharashtra State, India

editor@ijcrr.com

editor.ijcrr@gmail.com


Copyright © 2020 IJCRR. Specialized online journals by ubijournal .Website by Ubitech solutions